Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
News Log
Topics
Nordics
AI Docs
Soft Funding
Investors
AIDAVA
Research Wiki
Search
Search
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
IC Targets
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Special pages
Page information
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{DISPLAYTITLE:IC Targets}} {{Infobox company | name = IC Targets AS | org_number = 984531524 | founded = 2002-02-16 | employees = Not disclosed | address = Norway | industry = 72.100 β Biotechnology research | website = https://www.ictargets.com | nht_category = Startup | description = IC Targets (Norwegian Contrasts) is a life science company dedicated to developing manganese-based MRI contrast agents and new methods to improve diagnostic imaging. The company focuses on manganese as an alternative to gadolinium-based contrast agents, addressing concerns about gadolinium deposition in tissues. | notes = Founded 2002 β older than most NHT members. Manganese MRI contrast is an active research area addressing gadolinium safety concerns. | related_companies = [[NordicImagingLab]], [[Hemispherian]], [[Norway Health Tech]] | categories = Norway Health Tech, Startups, Diagnostics, Medical Imaging, Contrast Agents | sources = https://www.ictargets.com; https://data.brreg.no/enhetsregisteret/api/enheter/984531524 }} == About == IC Targets AS (Norwegian Contrasts) is a Norwegian life science company developing novel MRI contrast agents based on manganese chemistry. Founded in 2002, making it one of the oldest companies in the NHT cluster. == Technology == The company's core innovation is manganese-based MRI contrast agents. Conventional MRI contrast agents are based on gadolinium, which has raised safety concerns due to deposition in brain tissues and kidneys. Manganese is a naturally occurring mineral (essential trace element) that can serve as an alternative MRI contrast agent, potentially offering improved safety profiles. == Market Need == Gadolinium-based contrast agents are used in approximately 30-50% of MRI examinations globally. Growing concerns about gadolinium retention in the brain and other tissues have created interest in alternative contrast technologies. A manganese-based agent that maintains diagnostic efficacy while reducing safety concerns would address a significant market need. == References == <references/> [[Category:Norway Health Tech]] [[Category:Startups]] [[Category:Diagnostics]] [[Category:Medical Imaging]] [[Category:Contrast Agents]]
Summary:
Please note that all contributions to Research Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Research Wiki:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Template used on this page:
Template:Infobox company
(
edit
)
Toggle limited content width